Cetera Investment Advisers’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.22M | Buy |
9,888
+1,871
| +23% | +$610K | 0.01% | 1495 |
|
|
2025
Q1 | $2.16M | Buy |
8,017
+3,247
| +68% | +$877K | ﹤0.01% | 1693 |
|
|
2024
Q4 | $1.12M | Buy |
4,770
+1,902
| +66% | +$448K | ﹤0.01% | 2086 |
|
|
2024
Q3 | $789K | Buy |
2,868
+129
| +5% | +$35.5K | ﹤0.01% | 2290 |
|
|
2024
Q2 | $666K | Sell |
2,739
-819
| -23% | -$199K | ﹤0.01% | 2375 |
|
|
2024
Q1 | $532K | Buy |
3,558
+2,388
| +204% | +$357K | ﹤0.01% | 2558 |
|
|
2023
Q4 | $224K | Buy |
+1,170
| New | +$224K | ﹤0.01% | 1977 |
|
|
2023
Q2 | – | Sell |
-1,187
| Closed | -$238K | – | 2177 |
|
|
2023
Q1 | $238K | Buy |
1,187
+24
| +2% | +$4.81K | ﹤0.01% | 1839 |
|
|
2022
Q4 | $276K | Buy |
+1,163
| New | +$276K | ﹤0.01% | 1715 |
|
|
2022
Q1 | – | Sell |
-1,217
| Closed | -$206K | – | 1862 |
|
|
2021
Q4 | $206K | Buy |
+1,217
| New | +$206K | ﹤0.01% | 1721 |
|